nasdaq:idra
|
145000
|
May 19th, 2024 12:00AM
|
Idera Pharmaceuticals
|
4.0K
|
26.00
|
Open
|
|
May 19th, 2024 12:40AM
|
May 19th, 2024 12:07PM
|
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
|
Open
|
clinical development
|
Open
|
|
Durham
|
NC
|
US
|
|
|
Idera Pharmaceuticals
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:idra
|
145000
|
May 18th, 2024 12:00AM
|
Idera Pharmaceuticals
|
4.0K
|
26.00
|
Open
|
|
May 17th, 2024 11:51PM
|
May 18th, 2024 02:26PM
|
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
|
Open
|
clinical development
|
Open
|
|
Durham
|
NC
|
US
|
|
|
Idera Pharmaceuticals
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:idra
|
145000
|
May 17th, 2024 12:00AM
|
Idera Pharmaceuticals
|
4.0K
|
26.00
|
Open
|
|
May 16th, 2024 11:12PM
|
May 17th, 2024 09:17AM
|
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
|
Open
|
clinical development
|
Open
|
|
Durham
|
NC
|
US
|
|
|
Idera Pharmaceuticals
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:idra
|
145000
|
May 16th, 2024 12:00AM
|
Idera Pharmaceuticals
|
4.0K
|
26.00
|
Open
|
|
May 16th, 2024 12:33AM
|
May 16th, 2024 08:37AM
|
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
|
Open
|
clinical development
|
Open
|
|
Durham
|
NC
|
US
|
|
|
Idera Pharmaceuticals
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:idra
|
145000
|
May 15th, 2024 12:00AM
|
Idera Pharmaceuticals
|
4.0K
|
26.00
|
Open
|
|
May 14th, 2024 11:20PM
|
May 15th, 2024 12:41PM
|
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
|
Open
|
clinical development
|
Open
|
|
Durham
|
NC
|
US
|
|
|
Idera Pharmaceuticals
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:idra
|
145000
|
May 14th, 2024 12:00AM
|
Idera Pharmaceuticals
|
4.0K
|
26.00
|
Open
|
|
May 13th, 2024 11:09PM
|
May 14th, 2024 08:36AM
|
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
|
Open
|
clinical development
|
Open
|
|
Durham
|
NC
|
US
|
|
|
Idera Pharmaceuticals
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:idra
|
145000
|
May 13th, 2024 12:00AM
|
Idera Pharmaceuticals
|
4.0K
|
26.00
|
Open
|
|
May 12th, 2024 11:16PM
|
May 13th, 2024 07:54AM
|
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
|
Open
|
clinical development
|
Open
|
|
Durham
|
NC
|
US
|
|
|
Idera Pharmaceuticals
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:idra
|
145000
|
May 12th, 2024 12:00AM
|
Idera Pharmaceuticals
|
4.0K
|
26.00
|
Open
|
|
May 12th, 2024 01:21AM
|
May 12th, 2024 02:10PM
|
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
|
Open
|
clinical development
|
Open
|
|
Durham
|
NC
|
US
|
|
|
Idera Pharmaceuticals
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:idra
|
145000
|
May 11th, 2024 12:00AM
|
Idera Pharmaceuticals
|
4.0K
|
26.00
|
Open
|
|
May 10th, 2024 11:40PM
|
May 11th, 2024 05:18PM
|
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
|
Open
|
clinical development
|
Open
|
|
Durham
|
NC
|
US
|
|
|
Idera Pharmaceuticals
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:idra
|
145000
|
May 10th, 2024 12:00AM
|
Idera Pharmaceuticals
|
4.0K
|
26.00
|
Open
|
|
May 9th, 2024 11:13PM
|
May 10th, 2024 01:54PM
|
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
|
Open
|
clinical development
|
Open
|
|
Durham
|
NC
|
US
|
|
|
Idera Pharmaceuticals
|
Health Care
|
Health Care Equipment & Services
|